GIP receptors are present in various tissues such as the pancreas, adipose tissue, gastric mucosa, heart, adrenal cortex, bone and brain
Oral tirzepatide pills and sublingual drops are also being compounded, despite zero clinical trials or FDA evaluation of oral formulations
however, using any reputable, evidence-based tool can meaningfully support dietary adherence and long-term outcomes
(2024) "The new era of aspiration risk: The dilemma of GLP-1 receptor agonists," Journal of Perioperative Nursing: Vol
Loscos et al., 2008
Related Resources Explore additional peptide therapy resources to optimize your metabolic health journey: Semaglutide GLP-1 receptor agonist for appetite control and glucose regulation Tirzepatide Dual GIP/GLP-1 agonist for enhanced metabolic support CJC-1295/Ipamorelin Growth hormone secretagogue for muscle preservation and recovery Tesamorelin GHRH analog targeting visceral adipose tissue reduction Schedule a Peptide Therapy Consultation Discuss your metabolic optimization goals with our medical team